MARCOS
GONZÁLEZ DÍAZ
Investigador en el periodo 1993-2023
Erasmus University Medical Center
Róterdam, HolandaPublicaciones en colaboración con investigadores/as de Erasmus University Medical Center (23)
2017
-
Next Generation Flow for highly sensitive and standardized detection of minimal residual disease in multiple myeloma
Leukemia, Vol. 31, Núm. 10, pp. 2094-2103
2015
-
Subjects with chronic lymphocytic leukaemia-like B-cell clones with stereotyped B-cell receptors frequently show MDS-associated phenotypes on myeloid cells
British Journal of Haematology, Vol. 168, Núm. 2, pp. 258-267
2012
-
The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation
Leukemia, Vol. 26, Núm. 8, pp. 1821-1828
2011
-
Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens
Blood, Vol. 117, Núm. 6, pp. 1799-1805
-
Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy
Haematologica, Vol. 96, Núm. 10, pp. 1470-1477
-
Standardization of DNA isolation from low cell numbers for chimerism analysis by PCR of short tandem repeats
Leukemia, Vol. 25, Núm. 9, pp. 1467-1470
2010
-
Additional chromosome abnormalities in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and chemotherapy
Haematologica, Vol. 95, Núm. 3, pp. 424-431
2009
-
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis
Haematologica, Vol. 94, Núm. 9, pp. 1242-1249
-
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all- trans retinoic acid and anthracycline chemotherapy: Characteristics, outcome, and prognostic factors
Blood, Vol. 113, Núm. 4, pp. 775-783
2008
-
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin
Blood, Vol. 111, Núm. 7, pp. 3395-3402
-
Expanded cells in monoclonal TCR-άΒ+/CD4+/NKa+/CD8-/+dim T-LGL lymphocytosis recognize hCMV antigens
Blood, Vol. 112, Núm. 12, pp. 4609-4616
-
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: Long-term outcome of the LPA 99 multicenter study by the PETHEMA Group
Blood, Vol. 112, Núm. 8, pp. 3130-3134
2007
-
Characterization of a reference material for BCR-ABL (M-BCR) mRNA quantitation by real-time amplification assays: Towards new standards for gene expression measurements
Leukemia, Vol. 21, Núm. 7, pp. 1481-1487
-
Immunoglobulin gene rearrangements and the pathogenesis of multiple myeloma
Blood, Vol. 110, Núm. 9, pp. 3112-3121
-
Monoclonal TCR-Vβ13.1+/CD4+/NKa +/CD8-/+dim T-LGL lymphocytosis: Evidence for an antigen-driven chronic T-cell stimulation origin
Blood, Vol. 109, Núm. 11, pp. 4890-4898
2006
-
TCRγδ+ large granular lymphocyte leukemias reflect the spectrum of normal antigen-selected TCRγδ+ T-cells
Leukemia, Vol. 20, Núm. 3, pp. 505-513
2003
-
Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 concerted action BMH4-CT98-3936
Leukemia, Vol. 17, Núm. 12, pp. 2257-2317
-
Standardization and quality control studies of 'real time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - A Europe Against Cancer Program
Leukemia, Vol. 17, Núm. 12, pp. 2318-2357
2001
-
Immunoglobulin lambda isotype, gene rearrangements in B cell malignancies
Leukemia, Vol. 15, Núm. 1, pp. 121-127